Samir Shah | Global Head of Investor Relations |
Vas Narasimhan | Chief Executive Officer |
Marie-France | President of Novartis Pharmaceuticals |
Susanne Schaffert | President of Novartis Oncology |
Harry Kirsch | CFO |
John Tsai | Head of Global Drug Development and Chief Medical Officer for Novartis |
Wimal Kapadia | Bernstein |
Graham Parry | Bank of America |
Jo Walton | Credit Suisse |
Andrew Baum | Citi |
Mario Purcell | Morgan Stanley |
Emmanuel Papadakis | Deutsche Bank |
Richard Parkes | Exane BNP |
Seamus Fernandez | Guggenheim |
Kerry Holford | Berenberg |
Peter Welford | Jefferies |
Laura Sutcliffe | UBS |
Tim Anderson | Wolfe Research |
Simon Baker | Redburn |
Steve Scala | Cowen & Company |
Naresh Chouhan | Intron Health |
Keyur Parekh | Goldman Sachs |
Good morning and good afternoon, and welcome to the Novartis' Q2 2021 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a listen-only mode, and the conference is being recorded. [Operator Instructions] A recording of the conference call including the Q&A session will be available on our Web site shortly after the call ends. [Operator Instructions] With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations.